Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
April 1, 2025
After six months of anticoagulation maintenance, 2.5 mg BID dose of apixaban is not inferior to a full dose and showed less bleeding.
After six months of anticoagulation maintenance, 2.5 mg BID dose of apixaban is not inferior to a full dose and showed less bleeding.